Literature DB >> 27289275

Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.

Parisa Aghagolzadeh1, Matthias Bachtler2, Rakesh Bijarnia2, Christopher Jackson3, Edward R Smith4, Alex Odermatt5, Ramin Radpour1, Andreas Pasch6.   

Abstract

BACKGROUND AND AIMS: Vascular calcification is prevalent in clinical states characterized by low-grade chronic inflammation, such as chronic kidney disease (CKD). Calciprotein particles (CPP) are calcium phosphate-containing nano-aggregates, which have been found in the blood of CKD patients and appear pro-inflammatory in vitro. The interplay of CPPs and inflammatory cytokines with regard to the calcification of vascular smooth muscle cells (VSMC), in vitro, has not been investigated yet.
METHODS: Primary or secondary CPP were generated using phosphate-enriched culture medium (DMEM/10% FBS) incubated at 37 °C. Human VSMC were cultured with these media and mineralization was measured. Expression of TNF-α was detected by qPCR, ELISA and Western blot in calcified VSMC. To further characterize the significance of TNF-α and its receptors for the calcification of VSMC, RNA interference experiments using siTNF-α, siTNFR1 and siTNFR2 were performed.
RESULTS: The addition of phosphate to cell culture medium containing DMEM/10% FBS led to the rapid formation of primary CPP, which underwent spontaneous transformation to secondary CPP. Exposure of VSMC towards secondary CPP led to pronounced and concentration-dependent calcification, whereas exposure towards primary CPP did not. Importantly, secondary CPP induced oxidative stress, and led to the up-regulation and release of TNF-α. Addition of TNF-α to the cell culture medium enhanced, whereas the suppression of endogenous TNF-α or TNF receptor type 1 (TNFR1) expression by siRNA, ameliorated calcification.
CONCLUSIONS: Secondary, but not primary CPP, induce VSMC calcification. Secondary CPP induce the expression and release of TNF-α, which enhances calcification via its receptor TNFR1.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CPP; Calciprotein particles; Inflammation; Mineralization; TNF-α; Vascular smooth muscle cells

Mesh:

Substances:

Year:  2016        PMID: 27289275     DOI: 10.1016/j.atherosclerosis.2016.05.044

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  69 in total

Review 1.  The role of the gasotransmitter hydrogen sulfide in pathological calcification.

Authors:  Mariela Castelblanco; Sonia Nasi; Andreas Pasch; Alexander So; Nathalie Busso
Journal:  Br J Pharmacol       Date:  2019-07-24       Impact factor: 8.739

Review 2.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

Review 3.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

4.  The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.

Authors:  Iain Bressendorff; Ditte Hansen; Morten Schou; Andreas Pasch; Lisbet Brandi
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-21       Impact factor: 8.237

5.  Protein-bound calcium phosphate in uremic rat serum: a quantitative study.

Authors:  Hong-Xing Fan; Bao-Di Gou; Yu-Xi Gao; Gang Wu; Shu-Hu Liu; Fan Li; Tian-Lan Zhang
Journal:  J Biol Inorg Chem       Date:  2020-08-24       Impact factor: 3.358

6.  A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Yoshitsugu Obi; Chikako Monden; Tatsufumi Oka; Satoshi Yamaguchi; Isao Matsui; Nobuhiro Hashimoto; Ayumi Matsumoto; Karin Shimada; Yoshitsugu Takabatake; Atsushi Takahashi; Jun-Ya Kaimori; Toshiki Moriyama; Ryohei Yamamoto; Masaru Horio; Koichi Yamamoto; Ken Sugimoto; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2019-04-29       Impact factor: 10.121

7.  Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.

Authors:  Liang Dong; Yong Zhou; Zhao-Qiong Zhu; Tian Liu; Jia-Xi Duan; Jun Zhang; Ping Li; Bruce D Hammcok; Cha-Xiang Guan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 8.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

9.  Phosphate-induced ORAI1 expression and store-operated Ca2+ entry in aortic smooth muscle cells.

Authors:  Ke Ma; Ping Liu; Tamer Al-Maghout; Basma Sukkar; Hang Cao; Jakob Voelkl; Ioana Alesutan; Burkert Pieske; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2019-08-05       Impact factor: 4.599

Review 10.  Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.

Authors:  Berthold Hocher; Andreas Pasch
Journal:  Kidney Dis (Basel)       Date:  2017-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.